Zhiling Xiong, M.D., Ph.D.
Concepts are derived automatically from a person's publications.
Concepts are listed by decreasing relevance which is based on many factors, including how many publications the person wrote about that topic, how long ago those publications were written, and how many publications other people have written on that same topic.
| Name | Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
|---|
| Methohexital | 1 | 2017 | 17 | 0.560 |
Why?
|
| Malignant Hyperthermia | 1 | 2017 | 72 | 0.540 |
Why?
|
| Mitochondrial Myopathies | 1 | 2017 | 49 | 0.540 |
Why?
|
| Dexmedetomidine | 1 | 2017 | 321 | 0.400 |
Why?
|
| Blood Coagulation Disorders | 1 | 2014 | 350 | 0.370 |
Why?
|
| Analgesia, Epidural | 1 | 2014 | 332 | 0.370 |
Why?
|
| Hepatectomy | 1 | 2014 | 589 | 0.360 |
Why?
|
| Anesthesia, General | 1 | 2017 | 1188 | 0.330 |
Why?
|
| Pituitary Gland, Anterior | 2 | 1999 | 142 | 0.310 |
Why?
|
| Blood Coagulation | 1 | 2014 | 1163 | 0.310 |
Why?
|
| Anesthetics, Local | 3 | 2011 | 1005 | 0.250 |
Why?
|
| Sufentanil | 1 | 2017 | 42 | 0.140 |
Why?
|
| Lidocaine | 3 | 2011 | 545 | 0.130 |
Why?
|
| Potassium Channels | 1 | 1999 | 534 | 0.130 |
Why?
|
| Calcium Channel Blockers | 1 | 1998 | 687 | 0.120 |
Why?
|
| Calcium Channels | 1 | 1999 | 622 | 0.120 |
Why?
|
| Prothrombin Time | 1 | 2014 | 117 | 0.120 |
Why?
|
| GTP-Binding Proteins | 1 | 1999 | 946 | 0.120 |
Why?
|
| Partial Thromboplastin Time | 1 | 2014 | 203 | 0.110 |
Why?
|
| Epidural Space | 1 | 2014 | 123 | 0.110 |
Why?
|
| Fentanyl | 1 | 2017 | 451 | 0.110 |
Why?
|
| Liver Function Tests | 1 | 2014 | 527 | 0.100 |
Why?
|
| International Normalized Ratio | 1 | 2014 | 382 | 0.100 |
Why?
|
| Platelet Count | 1 | 2014 | 784 | 0.100 |
Why?
|
| Ketamine | 1 | 2017 | 527 | 0.090 |
Why?
|
| Catheterization | 1 | 2014 | 1429 | 0.080 |
Why?
|
| Fat Emulsions, Intravenous | 1 | 2011 | 314 | 0.070 |
Why?
|
| Resuscitation | 1 | 2011 | 681 | 0.070 |
Why?
|
| Heart Arrest | 1 | 2011 | 1516 | 0.050 |
Why?
|
| Patch-Clamp Techniques | 2 | 1999 | 924 | 0.040 |
Why?
|
| Receptors, Thyrotropin-Releasing Hormone | 1 | 1999 | 8 | 0.040 |
Why?
|
| Phorbol 12,13-Dibutyrate | 1 | 1999 | 40 | 0.040 |
Why?
|
| Guanosine 5'-O-(3-Thiotriphosphate) | 1 | 1999 | 87 | 0.040 |
Why?
|
| Thyrotropin-Releasing Hormone | 1 | 1999 | 139 | 0.040 |
Why?
|
| Dihydropyridines | 1 | 1998 | 67 | 0.040 |
Why?
|
| Liver | 1 | 2014 | 7571 | 0.040 |
Why?
|
| Nicardipine | 1 | 1998 | 59 | 0.040 |
Why?
|
| Somatostatin | 1 | 1999 | 459 | 0.030 |
Why?
|
| Ganglia, Spinal | 1 | 1999 | 529 | 0.030 |
Why?
|
| Membrane Potentials | 1 | 1998 | 1085 | 0.030 |
Why?
|
| Bupivacaine | 1 | 1998 | 414 | 0.030 |
Why?
|
| Clone Cells | 1 | 1998 | 1670 | 0.030 |
Why?
|
| Rats | 3 | 1999 | 23717 | 0.030 |
Why?
|
| Sodium | 1 | 1999 | 1594 | 0.030 |
Why?
|
| Treatment Outcome | 2 | 2017 | 65286 | 0.020 |
Why?
|
| Adult | 2 | 2017 | 223305 | 0.020 |
Why?
|
| Aged, 80 and over | 1 | 2014 | 59548 | 0.020 |
Why?
|
| Nervous System Diseases | 1 | 1999 | 1659 | 0.020 |
Why?
|
| Young Adult | 1 | 2014 | 59939 | 0.020 |
Why?
|
| Female | 2 | 2017 | 396532 | 0.020 |
Why?
|
| Dose-Response Relationship, Drug | 1 | 1998 | 10745 | 0.020 |
Why?
|
| Retrospective Studies | 1 | 2014 | 81657 | 0.020 |
Why?
|
| Calcium | 1 | 1999 | 5783 | 0.020 |
Why?
|
| Pain | 1 | 1999 | 5098 | 0.010 |
Why?
|
| Middle Aged | 2 | 2014 | 223267 | 0.010 |
Why?
|
| Humans | 3 | 2017 | 766812 | 0.010 |
Why?
|
| Aged | 1 | 2014 | 171344 | 0.010 |
Why?
|
| Male | 3 | 2014 | 364154 | 0.010 |
Why?
|
| Neurons | 1 | 1999 | 9515 | 0.010 |
Why?
|
| Animals | 3 | 1999 | 168939 | 0.010 |
Why?
|
| Electric Conductivity | 1 | 1999 | 405 | 0.010 |
Why?
|
| Tetrodotoxin | 1 | 1999 | 243 | 0.010 |
Why?
|
| Electrophysiology | 1 | 1999 | 1263 | 0.010 |
Why?
|
| Constriction, Pathologic | 1 | 1999 | 1104 | 0.010 |
Why?
|
| Drug Resistance | 1 | 1999 | 1592 | 0.010 |
Why?
|
| Rats, Sprague-Dawley | 1 | 1999 | 8108 | 0.000 |
Why?
|